German pharma group Cheplapharm is planning to list on the stock exchange in the second half of the year in a deal that could value the company at 10-12 billion euros ($11.8-14.1 billion), including …
( read original story …)
The Japan News
German pharma group Cheplapharm is planning to list on the stock exchange in the second half of the year in a deal that could value the company at 10-12 billion euros ($11.8-14.1 billion), including …
( read original story …)